Ethomidate
CAS : 15301-65-2
Ref. 3D-QAA30165
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 25g | Arrêté | ||
| 25mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Ethomidate
Description :
Ethomidate is an analog of the anesthetic etomidate that has been found to have anticancer properties. It inhibits the activity of kinases, which are enzymes that regulate cell growth and division. Ethomidate has been shown to induce apoptosis, or programmed cell death, in cancer cells by inhibiting elastase activity. It also inhibits the growth of tumors in mice with human cancer cell xenografts. Ethomidate has potential as a therapeutic agent for the treatment of cancer and may be useful as a kinase inhibitor in other diseases as well. Its effectiveness can be measured through urine analysis and it has shown promising results in preclinical studies.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
244.29 g/mol
Formule :
C14H16N2O2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
